Brief: Mezzion Secures Strategic Financing To Support Advancement Of Global Phase 3 Fuel-2 Trial In Fontan Patients
14/05/2026 12:04
Mezzion Pharma Co Ltd 140410.KQ: MEZZION SECURES STRATEGIC FINANCING TO SUPPORT ADVANCEMENT OF GLOBAL PHASE 3 FUEL-2 TRIAL IN FONTAN PATIENTS Source text: ID:nPn5FhkH8a Further company coverage: 140410.KQ
Recent news on Mezzion Pharma
See all newsBrief: Mezzion Secures Strategic Financing To Support Advancement Of Global Phase 3 Fuel-2 Trial In Fontan Patients
Brief: Mezzion Reports Pre-Ind FDA Feedback On The Development Of Udenafil In Adpkd
Brief: Mezzion Pharmaceuticals Appoints Ridwan Shabsigh As President & Chief Operating Officer
Brief: Mezzion Pharmaceuticals Reaches Key Enrollment Milestone In World's Largest Fontan Clinical Trial
Brief: Mezzion Pharmaceuticals Announces Dr Rahul Rathod As Global Principal Investigator For The Confirmatory Pivotal Phase 3 Trial FUEL-2